Zapata Quantum, Inc. financials

ZPTA CIK 0001843714

Source: EDGAR filings · Built 2026-06-19T01:48:47Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2022
Free Cash Flow -18.14M
EBITDA -22.93M -17.94M
Working Capital -8.70M -21.47M -3.80M 1.09M -581.46K
Net Debt 4.41M 4.13M 8.91M 0
Gross Margin 16.38% 19.37%
Operating Margin -594.58% -318.63%
Net Margin -984.08% -523.21%
Return on Equity (ROE) -112.93% 162.50% 290.77% -3.31% -76.82%
Return on Assets (ROA) 410.92% -1395.65% -368.59% 0.79% -1.82%
Current Ratio 0.17× 0.09× 0.60× 10.46× 0.00×
Debt-to-Equity -0.53× -0.18× -1.13× 0.00×
Effective Tax Rate -0.05% -0.07%
Cash Conversion Ratio -0.18× 0.47× 0.50× -1.02× 0.73×
Accruals Ratio 4.84× -7.33× -1.86× 0.02× -0.00×
SBC % of Revenue 0.00% 13.65%
CapEx Coverage -532.59×
Free Cash Flow Per Share $-0.62

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2022
Revenues 3.88M 5.68M
Cost of Revenue 3.24M 4.58M
Gross Profit 635.00K 1.10M
Research and Development Expense 252.00K 4.42M 5.92M
Operating Expenses 3.43M 23.68M 19.21M
Operating Income (Loss) -3.43M -23.05M -18.11M -1.51M -10.86K
Income Tax Expense (Benefit) 20.00K 20.00K 0
Net Income (Loss) Attributable to Parent 9.34M -38.14M -29.73M 1.89M -10.86K
Earnings Per Share, Basic $0.09 $-1.30 $-5.82
Weighted Average Number of Shares Outstanding, Basic 101.86M 29.43M 4.66M
Earnings Per Share, Diluted $0.04 $-1.30 $-5.82
Weighted Average Number of Shares Outstanding, Diluted 227.40M 29.43M 4.66M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2022
Cash and Cash Equivalents, at Carrying Value 0 38.00K 2.69M 0 0
Assets, Current 1.84M 2.18M 5.59M 1.21M 2.05K
Assets 2.27M 2.73M 8.07M 240.38M 597.65K
Long-term Debt 2.55M 8.90M
Liabilities, Current 10.54M 23.66M 9.39M 115.35K 583.51K
Liabilities 10.54M 26.21M 18.29M 8.33M 583.51K
Stockholders' Equity Attributable to Parent -8.27M -23.47M -10.23M -57.08M 14.14K
Common Stock, Shares, Outstanding 172.32M 43.59M 4.68M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2022
Net Cash Provided by (Used in) Operating Activities -1.67M -18.11M -14.76M -1.93M -7.91K
Payments to Acquire Property, Plant, and Equipment 34.00K
Net Cash Provided by (Used in) Investing Activities -34.00K 161.04M -235.75M 0
Payments for Repurchase of Common Stock 161.04M
Net Cash Provided by (Used in) Financing Activities 3.02M 15.10M 8.04M 238.30M 7.91K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ZPTA CIK 0001843714), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

HSTM

HEALTHSTREAM INC

RNA

Atrium Therapeutics, Inc.

AXS-PE

AXIS CAPITAL HOLDINGS LIMITED